Industry
Pharmaceuticals
Topic
Product Launch
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Product Launch in Pharmaceuticals
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the Ministry of Health, Labor and Welfare ...
... PreAngel Fund. Qu Lei, Energo Labs CEO and Founder. SAIF Partners, CollinStar, Blockchain Ventures, Nood Capital, Ink Labs Foundation, SpaceChain Foundation, Hua Ying Group, etc. ...
... postpone the Meeting to allow discussions regarding a possible transaction with Aurora Cannabis Inc. ("Aurora") as permitted under the terms of the Arrangement Agreement between ...
... for Two-Month ARISTADA Lundbeck & Otsukaâ(EURO)(TM)s Brexpiprazole gets Approval from EMA Sumitomo Dainippon Pharma gets Import Drug License Approval from CFDA Minoryxâ(EURO)(TM)s MIN-102 gets Orphan ...
... Corporate Wire Date: 17 January 2018 15:30 EST ORIGINAL ANNOUNCEMENT [Text] CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") is pleased to announce the launch ...
... CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") is pleased to announce the launch ...
... Phivida Holdings Inc. ("C.VIDA" or "OTCMKTS.PHVAF") announces the global launch of the latest CBD ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), along with new collaborators AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and Pfizer Inc., today announced the formation of a ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs - ...
... Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering ...
... BERKELEY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that HEPLISAV-B„¢ [Hepatitis B Vaccine (Recombinant), Adjuvanted] is ...
... TIGIT antagonist PTZ-201 (ASP8374) which is being developed in partnership with Astellas Pharma Inc. and its affiliates ("Astellas"). In addition, Potenza and Astellas are jointly ...
... CANADIAN DAILY STOCK REPORT ICC Labs, Inc. (TSXV:ICC), Canada's 48th largest Oil & gas - exploration & production ...
... CANADIAN DAILY STOCK REPORT ICC Labs, Inc. (TSXV:ICC), Canada's 48th largest Oil & gas - exploration & production ...
... the HMMJ portfolio TORONTO, Dec. 18, 2017 Canada NewsWire December 14: ICC International Cannabis Corporation Changes its Name to ICC Labs Inc. to Reflect Medicinal ...
... Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that ...
... Otsuka Pharmaceutical Co., Ltd. (Otsuka) and X-Chem, Inc. (X-Chem) announce that they have signed a collaborative research agreement to advance ...
... expanded to include the following constituents: Source: TMX Group SECTION 1 ICC INTERNATIONAL CANNABIS ACTIVITIES ICC International Cannabis Corp is a cannabis producer. It is ...
... 2017, -- ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a clinical collaboration to advance ISA101, an immunotherapy ...
... CANADIAN DAILY STOCK REPORT Medicure Inc. (TSXV:MPH), Canada's 15th largest Biotechnology company by market cap, has decreased 3.0c ...
... TARRYTOWN, N.Y. and PARIS - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive topline results from a pivotal ...
... ANNOUNCEMENT [Text] VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 14, 2017) - ICC Labs Inc. ("ICC Labs" or the "Company") (TSX VENTURE:ICC), a fully licensed producer and ...
... Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that, ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced updates related to its collaboration programs with Sanofi, ...
... unmet need in advanced CSCC," said Elias Zerhouni, MD, President, Global R&D, Sanofi. "We look forward to working with regulatory agencies globally to bring this ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous ...
Want to see the full history on Product Launch in Pharmaceuticals? Upgrade to RelSci Pro now!
Start My Free Trial